Pandemic Influenza International Scientific Conference
Health Protection Agency (HPA)
Monday-Tuesday, 21-22 June, London
This two day international conference, convened by the Health Protection Agency, will bring together scientists, academics and clinicians to consider lessons learned since the appearance of pandemic H1N1 in April 2009. Principal themes of the conference will be: virology and sero-epidemiology; epidemiology and modelling; epidemiology and surveillance; vaccination; antivirals; and lessons learnt. Clinical, public health and other scientific research findings will be presented and the Health Protection Agency will showcase certain aspects of its work to stakeholders, government agencies and other partners. Abstracts of proposed poster presentations are invited.
Key objectives are to provide a forum for exchange of information on:
Health Protection 2010
Health Protection Agency
14-15 September 2010, Warwick University
The HPA's annual conference and exhibition this year includes five parallel symposia on each of two days, as follows:
Tuesday 14 September
Epidemiology
Hepatitis and other bloodborne viruses
Foodborne infections
Emerging threats and CBRN emergencies.
Swine flu and vaccines.
Wednesday 15 September
Tuberculosis
Healthcare associated infections/AMR
Environmental hazards to health
Emergency response
New technologies/sequencing
Practical issues in clinical mycology
UK Clinical Mycology Network (UKCMN)
Monday, 7 June, Royal College of Pathologists, London
A one-day, practically-orientated meeting for staff at centres that provide clinical mycology services covering: direct microscopy and diagnostic problems in routine laboratory work; the histopathology of fungal infections; radiology; anti-fungals; fungal serology; and molecular identification. There will be discussion of issues encountered by delegates during their routine diagnostic work or in the management of patients with fungal infections.
UKCMN aims to provide a structure for the UK-wide coordination of mycology service delivery, mycological surveillance, medical and laboratory training, diagnostic development and translational research.
Reducing HCAIs - 2010: a health economy approach to quality care
GovToday
Wednesday, 16 June 2010, London.
This national conference is the fourth in a series of events concerned with reducing healthcare associated infections (HCAIs). The context is the recent Public Accounts Committee Report that recommended a health economy-wide approach to infection control and that all healthcare providers should adopt a “zero tolerance” approach to HCAI control. The event will include contributions from both national and international experts, interactive master classes and an exhibition and networking area providing a forum for sharing innovation, expertise and best practice across the sector.
Practical Aspects of Infection Control
Sheffield Teaching Hospitals / Hallam University with the Hospital Infection Society
Monday-Tuesday, 21-22 June, Sheffield Hallam University, Sheffield
The 13th Don't Panic! meeting is intended for microbiologists and infection control nurses, public health staff and biomedical scientists. Lectures will cover: PVL – diversity, demographics and disease burden in the UK; Flu season 2009/10 – how well did we do? Specifications for invasive procedures performed away from operating theatres; Post-discharge surveillance of SSI – making it work; Update on C.difficile surveillance; Treating complex C. difficile infection; Occupational health issues (chronic MRSA carriage, managing dermatitis, skincare choices for hand washes and alcohol rubs); The Showcase Hospitals Programme; Practical aspects of ensuring a safe water supply; Universal screening for controlling MRSA – the Scottish experience; and MRSA screening and decolonization in the community: is the community up to it?
Health Protection Agency (HPA)
Monday-Tuesday, 21-22 June, London
This two day international conference, convened by the Health Protection Agency, will bring together scientists, academics and clinicians to consider lessons learned since the appearance of pandemic H1N1 in April 2009. Principal themes of the conference will be: virology and sero-epidemiology; epidemiology and modelling; epidemiology and surveillance; vaccination; antivirals; and lessons learnt. Clinical, public health and other scientific research findings will be presented and the Health Protection Agency will showcase certain aspects of its work to stakeholders, government agencies and other partners. Abstracts of proposed poster presentations are invited.
Key objectives are to provide a forum for exchange of information on:
- the virology of the pandemic virus
- the epidemiology and clinical presentation of pandemic influenza infection
- issues related to real-time modelling and impact of guidance and policies
- effectiveness and issues relating to clinical counter-measures.
Health Protection 2010
Health Protection Agency
14-15 September 2010, Warwick University
The HPA's annual conference and exhibition this year includes five parallel symposia on each of two days, as follows:
Tuesday 14 September
Epidemiology
Hepatitis and other bloodborne viruses
Foodborne infections
Emerging threats and CBRN emergencies.
Swine flu and vaccines.
Wednesday 15 September
Tuberculosis
Healthcare associated infections/AMR
Environmental hazards to health
Emergency response
New technologies/sequencing
Practical issues in clinical mycology
UK Clinical Mycology Network (UKCMN)
Monday, 7 June, Royal College of Pathologists, London
A one-day, practically-orientated meeting for staff at centres that provide clinical mycology services covering: direct microscopy and diagnostic problems in routine laboratory work; the histopathology of fungal infections; radiology; anti-fungals; fungal serology; and molecular identification. There will be discussion of issues encountered by delegates during their routine diagnostic work or in the management of patients with fungal infections.
UKCMN aims to provide a structure for the UK-wide coordination of mycology service delivery, mycological surveillance, medical and laboratory training, diagnostic development and translational research.
Reducing HCAIs - 2010: a health economy approach to quality care
GovToday
Wednesday, 16 June 2010, London.
This national conference is the fourth in a series of events concerned with reducing healthcare associated infections (HCAIs). The context is the recent Public Accounts Committee Report that recommended a health economy-wide approach to infection control and that all healthcare providers should adopt a “zero tolerance” approach to HCAI control. The event will include contributions from both national and international experts, interactive master classes and an exhibition and networking area providing a forum for sharing innovation, expertise and best practice across the sector.
- Dr Christine McCartney, executive director of the HPA Regional Microbiology Network, opened the previous event in the series, “Reducing HCAIs - quality, innovation and care” held in London in February, that was attended by more than 450 delegates. The keynote address was given by Professor Didier Pittet, WHO representative and director of the Infection Control Programme at the University of Geneva Hospitals and Faculty of Medicine Geneva, Switzerland.
Practical Aspects of Infection Control
Sheffield Teaching Hospitals / Hallam University with the Hospital Infection Society
Monday-Tuesday, 21-22 June, Sheffield Hallam University, Sheffield
The 13th Don't Panic! meeting is intended for microbiologists and infection control nurses, public health staff and biomedical scientists. Lectures will cover: PVL – diversity, demographics and disease burden in the UK; Flu season 2009/10 – how well did we do? Specifications for invasive procedures performed away from operating theatres; Post-discharge surveillance of SSI – making it work; Update on C.difficile surveillance; Treating complex C. difficile infection; Occupational health issues (chronic MRSA carriage, managing dermatitis, skincare choices for hand washes and alcohol rubs); The Showcase Hospitals Programme; Practical aspects of ensuring a safe water supply; Universal screening for controlling MRSA – the Scottish experience; and MRSA screening and decolonization in the community: is the community up to it?
A substance that acts against viruses, for example and antiviral drug.
Full medical glossary
A fluid that transports oxygen and other substances through the body, made up of blood cells suspended in a liquid.
Full medical glossary
A disease of long duration generally involving slow changes.
Full medical glossary
The large intestine.
Full medical glossary
A viral infection affecting the respiratory system.
Full medical glossary
Invasion by organisms that may be harmful, for example bacteria or parasites.
Full medical glossary
A viral infection affecting the respiratory system.
Full medical glossary
An element present in haemoglobin in the red cells.
Full medical glossary
A large abdominal organ that has many important roles including the production of bile and clotting factors, detoxification, and the metabolism of proteins, carbohydrates and fats.
Full medical glossary
The use of microscopes to investigate objects too small to be seen with the naked eye.
Full medical glossary
The study of fungi.
Full medical glossary
An outbreak of infection that affects numerous people in different countries.
Full medical glossary
per vaginam
Full medical glossary
septic arthritis
Full medical glossary
A way to identify people who may have a certain condition, among a group of people who may or may not seem to
Full medical glossary
Analysis of blood serum.
Full medical glossary
The means of producing immunity by stimulating the formation of antibodies.
Full medical glossary
A microbe that is only able to multiply within living cells.
Full medical glossary
Microbes that are only able to multiply within living cells.
Full medical glossary